Sangsang Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sangsang Tang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Junfen Xu
Department of Gynecologic Oncology, Women's Hospital Zhejiang University School of Medicine Hangzhou China
18 shared publications - Yuanming Shen
Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
18 shared publications - Kelie Chen
Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
17 shared publications - Sen Li
Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
17 shared publications - Weidong Fei
Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
17 shared publications - Weiguo Lu
Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
17 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (6)
Performance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal masses
To enhance ovarian cancer diagnosis by establishing multi-parameter differential diagnostic models, combining preoperative blood tests and ultrasonic examination. This was a retrospective cohort study. Adult women with adnexal lesions who underwent surgery between January 2013 and December 2019 were included in the study. We performed various blood tests (including routine blood work, biochemistry, thyroid hormone, reproductive hormones, and tumor markers) and ultrasonic examination on 2,929 participants. Based on these clinical features, diagnostic models were constructed and validated using the eXtreme Gradient Boosting (XGBoost) algorithm and logistic regression. Among the 2,929 participants with adnexal masses, 2,117 participants had benign conditions (574 ovarian cysts, 1,376 ovarian tumors, and 167 ovarian endometriomas), 311 had borderline ovarian tumors, and 501 had invasive ovarian cancer (413 epithelial and 88 non-epithelial types). Initially, full-feature modeling achieves area under the curve (AUC) values of 1.00 and 0.97 for the diagnosis of epithelial ovarian cancer in the training and validation sets, respectively, using a set of 20 feature parameters. Similarly, a set of 30 feature parameters yield AUCs of 1.00 (training) and 0.97 (validation) for the diagnosis of invasive ovarian cancer. XGBoost outperformed other modeling algorithms in predictive values. The differential diagnostic models constructed from multiple feature parameters exhibited better calibration than the model based on a single parameter of cancer antigen 125. This study established effective multi-parameter differential diagnostic models to differentiate ovarian cancer from adnexal masses, demonstrating their potential to enhance diagnostic accuracy.
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (6)
Open AccessPerformance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal masses
To enhance ovarian cancer diagnosis by establishing multi-parameter differential diagnostic models, combining preoperative blood tests and ultrasonic examination. This was a retrospective cohort study. Adult women with adnexal lesions who underwent surgery between January 2013 and December 2019 were included in the study. We performed various blood tests (including routine blood work, biochemistry, thyroid hormone, reproductive hormones, and tumor markers) and ultrasonic examination on 2,929 participants. Based on these clinical features, diagnostic models were constructed and validated using the eXtreme Gradient Boosting (XGBoost) algorithm and logistic regression. Among the 2,929 participants with adnexal masses, 2,117 participants had benign conditions (574 ovarian cysts, 1,376 ovarian tumors, and 167 ovarian endometriomas), 311 had borderline ovarian tumors, and 501 had invasive ovarian cancer (413 epithelial and 88 non-epithelial types). Initially, full-feature modeling achieves area under the curve (AUC) values of 1.00 and 0.97 for the diagnosis of epithelial ovarian cancer in the training and validation sets, respectively, using a set of 20 feature parameters. Similarly, a set of 30 feature parameters yield AUCs of 1.00 (training) and 0.97 (validation) for the diagnosis of invasive ovarian cancer. XGBoost outperformed other modeling algorithms in predictive values. The differential diagnostic models constructed from multiple feature parameters exhibited better calibration than the model based on a single parameter of cancer antigen 125. This study established effective multi-parameter differential diagnostic models to differentiate ovarian cancer from adnexal masses, demonstrating their potential to enhance diagnostic accuracy.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Figure from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Data from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
Supplementary Table from Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer